在心脏手术期间的可佩素水平
Selma Samuelsson1, Lars Engerström2, Jonas Holm1
1Department of Cardiothoracic and Vascular Surgery, Linköping University Hospital and Department of Health, Medicine and Caring Sciences, Unit of Cardiovascular Medicine, Linköping University, Linköping, Sweden.
Journal of cardiothoracic and vascular anesthesia
|March 1, 2025
概括
在成人心脏手术期间,可佩的水平显著上升,心肺旁路 (CPB),在CPB启动后很早达到峰值. 这些升高的可佩水平表明阿尔金因压素系统的激活,并可能作为预后标志物.
科学领域:
- 心血管外科心血管外科
- 内分泌学 在内分泌学.
- 关键护理医学 关键护理医学
背景情况:
- 成人心脏外科手术的术后过程涉及复杂的生理变化.
- 了解神经激素反应,如可佩水平,对于患者管理至关重要.
- 氨酸血管压素系统的激活与各种压力状况有关.
研究的目的:
- 在整个外科手术前期内检查成年心脏手术患者进行心肺绕道手术 (CPB) 的可佩丁水平.
- 为了表征响应手术压力和CPB的可佩丁度的动态变化.
- 探索平素作为该患者群体中预后标记物的潜力.
主要方法:
- 一项前性队列研究,涉及57名接受CPB开放心脏手术的成人患者.
- 科佩水平在多个时间点测量:手术前,手术期间 (胸膜切除,CPB启动和终止) 和术后 (ICU,4天).
- 根据手术前的科佩水平相对于10 pmol/L的参考值,患者被分组.
主要成果:
- 素水平从手术前的中位数 (6.6 pmol/L) 显著增加到胸腔切除术后的27 pmol/L (p ≤ 0.001).
- 在CPB开始后60分钟观察到峰值素水平 (中位数为286 pmol/L),直到CPB终止后仍然显著升高.
- 在术后,科佩水平逐渐下降,但在4天内仍然明显高于手术前水平 (11.5 pmol/L; p ≤ 0.001).
结论:
- 患有CPB的成人心脏手术与阿尔金压缩系统的深度和持续激活有关,可通过显著升高的可佩水平来表明.
- 在CPB期间可佩提升的幅度可能超过其他严重疾病 (如败血症休克) 中所见的水平.
- 这些发现支持进一步研究copeptin作为心脏手术患者预后指标的作用.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
79
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
79
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
41
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
41
01:26Heart Failure Drugs: Inotropic Agents
495
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
495